246 Fully Vaccinated People in Michigan Test Positive for COVID-19; 3 Dead

0

Michigan data show that 246 residents have tested positive for COVID-19 more than two weeks after being fully vaccinated against the virus that causes it.

The potential so-called vaccine breakthrough cases were recorded between Jan. 1 and March 31.

Eleven of the residents were hospitalized and three died, a spokesperson with the state Department of Health and Human Services (MDDHS) told The Epoch Times via email. The people who died were all 65 years of age or older.

Data about hospitalization status for 129 cases were incomplete, and for the other set, hospitalization status for 3 cases was reported as unknown.

The fully vaccinated cases were identified through weekly reviews of data on all confirmed and probable cases of COVID-19, the disease caused by the CCP virus. State officials compare the data to records of every person who has been fully vaccinated.

Fully vaccinated means two weeks have elapsed since a person has received two doses of the Pfizer or Moderna vaccine, or the single-shot Johnson & Johnson vaccine.

“These are individuals who have had a positive test 14 or more days after the last dose in the vaccine series. Some of these individuals may ultimately be excluded from this list due to continuing to test positive from a recent infection prior to being fully vaccinated. These cases are undergoing further review to determine if they meet other CDC criteria for determination of potential breakthrough, including the absence of a positive antigen or PCR test less than 45 days prior to the post-vaccination positive test,” the spokesperson said.

“In general, these persons have been more likely to be asymptomatic or mildly symptomatic compared with vaccinated persons. Please note, to date, more than 1.7 million Michiganders have completed their COVID-19 vaccine. Some of these cases may be ruled out via additional investigation.”

According to the Food and Drug Administration, Pfizer’s vaccine is considered 95 percent effective in preventing severe symptoms of COVID-19. Moderna’s is 94 percent, and Johnson & Johnson’s is approximately 67 percent.

Source: The epochtimes

Share.